Literature DB >> 8104196

X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis.

D G Bichet1, M F Arthus, M Lonergan, G N Hendy, A J Paradis, T M Fujiwara, K Morgan, M C Gregory, W Rosenthal, A Didwania.   

Abstract

In X-linked nephrogenic diabetes insipidus (NDI) the urine of male patients is not concentrated after the administration of the antidiuretic hormone arginine-vasopressin. This disease is due to mutations in the V2 receptor gene that maps to chromosome region Xq28. In 1969, Bode and Crawford suggested that most NDI patients in North America shared common ancestors of Ulster Scot immigrants who arrived in Halifax in 1761 on the ship Hopewell. A link between this family and a large Utah kindred was also suggested. DNA was obtained from 17 affected male patients from the "Hopewell" kindred and from four additional families from Nova Scotia and New Brunswick who shared the same Xq28 NDI haplotype. The Utah kindred and two families (Q2, Q3) from Quebec were also studied. The "Hopewell" mutation, W71X, is a single base substitution (G-->A) that changes codon 71 from TGG (tryptophan) to TGA (stop). The W71X mutation was found in affected members of the Hopewell and of the four satellite families. The W71X mutation is the cause of X-linked NDI for the largest number of related male patients living in North America. Other families (Utah, Q2 and Q3) that are historically and ethnically unrelated bear other mutations in the V2 receptor gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104196      PMCID: PMC288266          DOI: 10.1172/JCI116698

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

Review 1.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors.

Authors:  T M Savarese; C M Fraser
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

2.  Derivatives of somatic cell hybrids which carry the human gene locus for nephrogenic diabetes insipidus (NDI) express functional vasopressin renal V2-type receptors.

Authors:  D A Jans; B A van Oost; H H Ropers; F Fahrenholz
Journal:  J Biol Chem       Date:  1990-09-15       Impact factor: 5.157

3.  Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.

Authors:  D G Bichet; M Razi; M Lonergan; M F Arthus; V Papukna; C Kortas; J N Barjon
Journal:  N Engl J Med       Date:  1988-04-07       Impact factor: 91.245

4.  Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors.

Authors:  S Libber; H Harrison; D Spector
Journal:  J Pediatr       Date:  1986-02       Impact factor: 4.406

5.  Nephrogenic diabetes insipidus in North America. The Hopewell hypothesis.

Authors:  H H Bode; J D Crawford
Journal:  N Engl J Med       Date:  1969-04-03       Impact factor: 91.245

6.  Nephrogenic diabetes insipidus in a Negro kindred.

Authors:  R D Feigin; D L Rimoin; R L Kaufman
Journal:  Am J Dis Child       Date:  1970-07

7.  Localization of the gene for X-linked nephrogenic diabetes insipidus to Xq28.

Authors:  M Kambouris; S R Dlouhy; J A Trofatter; P M Conneally; M E Hodes
Journal:  Am J Med Genet       Date:  1988-01

8.  Brief report: a mutation in the vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus.

Authors:  J J Merendino; A M Speigel; J D Crawford; A M O'Carroll; M J Brownstein; S J Lolait
Journal:  N Engl J Med       Date:  1993-05-27       Impact factor: 91.245

9.  Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus.

Authors:  W Rosenthal; A Seibold; A Antaramian; M Lonergan; M F Arthus; G N Hendy; M Birnbaumer; D G Bichet
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

10.  Colocalization of the gene for nephrogenic diabetes insipidus (DIR) and the vasopressin type 2 receptor gene (AVPR2) in the Xq28 region.

Authors:  A M van den Ouweland; M T Knoop; V V Knoers; P W Markslag; M Rocchi; S T Warren; H H Ropers; F Fahrenholz; L A Monnens; B A van Oost
Journal:  Genomics       Date:  1992-08       Impact factor: 5.736

View more
  27 in total

1.  V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.

Authors:  Kazuhiro Takahashi; Noriko Makita; Katsunori Manaka; Masataka Hisano; Yuko Akioka; Kenichiro Miura; Noriyuki Takubo; Atsuko Iida; Norishi Ueda; Makiko Hashimoto; Toshiro Fujita; Takashi Igarashi; Takashi Sekine; Taroh Iiri
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

Review 2.  Advances in endocrinology.

Authors:  P E Clayton; V Tillmann
Journal:  Arch Dis Child       Date:  1998-03       Impact factor: 3.791

3.  Molecular Architecture of G Protein-Coupled Receptors.

Authors:  A Michiel van Rhee; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1996-01-01       Impact factor: 4.360

4.  A case of nephrogenic diabetes insipidus with a novel missense mutation in the AVPR2 gene.

Authors:  Akira Ashida; Daisuke Yamamoto; Hyogo Nakakura; Hideki Matsumura; Shinichi Uchida; Sei Sasaki; Hiroshi Tamai
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

5.  Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells.

Authors:  S H Pearce; M Bai; S J Quinn; O Kifor; E M Brown; R V Thakker
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

6.  Novel and recurrent variants in AVPR2 in 19 families with X-linked congenital nephrogenic diabetes insipidus.

Authors:  Shivani Joshi; Helene Kvistgaard; Konstantinos Kamperis; Mia Færch; Søren Hagstrøm; Niels Gregersen; Søren Rittig; Jane Hvarregaard Christensen
Journal:  Eur J Pediatr       Date:  2018-03-28       Impact factor: 3.183

7.  Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus.

Authors:  D G Bichet; M Birnbaumer; M Lonergan; M F Arthus; W Rosenthal; P Goodyer; H Nivet; S Benoit; P Giampietro; S Simonetti
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

8.  Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus.

Authors:  Haruo Mizuno; Yukari Sugiyama; Yoichiro Ohro; Hiroki Imamine; Masanori Kobayashi; Sei Sasaki; Sinichi Uchida; Hajime Togari
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

9.  Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2.

Authors:  Sei Sasaki; Motoko Chiga; Eriko Kikuchi; Tatemitsu Rai; Shinichi Uchida
Journal:  Clin Exp Nephrol       Date:  2012-11-14       Impact factor: 2.801

10.  Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  N Janicic; Z Pausova; D E Cole; G N Hendy
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.